Your browser doesn't support javascript.
loading
The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer.
Beadnell, Thomas C; Mishall, Katie M; Zhou, Qiong; Riffert, Stephen M; Wuensch, Kelsey E; Kessler, Brittelle E; Corpuz, Maia L; Jing, Xia; Kim, Jihye; Wang, Guoliang; Tan, Aik Choon; Schweppe, Rebecca E.
Afiliación
  • Beadnell TC; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Mishall KM; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Zhou Q; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Riffert SM; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Wuensch KE; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Kessler BE; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Corpuz ML; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Jing X; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Kim J; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Wang G; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.
  • Tan AC; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.
  • Schweppe RE; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado. Rebecca.Schweppe@ucdenver.edu.
Mol Cancer Ther ; 15(8): 1952-63, 2016 08.
Article en En | MEDLINE | ID: mdl-27222538
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Familia-src Quinasas / Resistencia a Antineoplásicos / Sistema de Señalización de MAP Quinasas / Inhibidores de Proteínas Quinasas / Dasatinib / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Familia-src Quinasas / Resistencia a Antineoplásicos / Sistema de Señalización de MAP Quinasas / Inhibidores de Proteínas Quinasas / Dasatinib / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos